IL-9 can promote the formation and function of osteoclasts through the M-CSF/sRANKL signaling pathway, which in turn regulates the expression of matrix metalloproteinases (MMPs) and ultimately leads to bone damage in RA [90]. The gene discussed is IL9; the disease is rheumatoid arthritis.